Yoo: Incumbent health insurers have not solved cross-plan treatment underwriting
Julie Yoo · When Two Giants Intersect: Healthcare Meets Fintech · May 9, 2023 · at 45:28
Julie Yoo, General Partner at Andreessen Horowitz (a16z), discusses why traditional health insurers struggle to cover high-upfront-cost treatments like GLP-1s and gene therapies given short employee job tenures.
0:00 / 0:04exact quote · 4.3s
▶ Watch the full episode on YouTube → 720p mp4 · rendered on demand · StarZero watermark
“We've spent a lot of time with incumbent insurance carriers. They have not figured this out yet.”
quote is from the automated transcript, cleaned for reading: filler sounds and stutters are removed, nothing is rephrased. names can be misheard (the analysis reads context, assessments check outside sources). how →
More from Julie Yoo
Yoo: AI task unbundling could nearly double clinical workforce capacity
“So, you know, imagine like almost doubling the capacity of a given clinical labor pool simply by applying some of these unbundling tactics.”
Yoo: Healthcare's lack of SaaS legacy enables faster AI adoption
“One of the dynamics that we believe is driving this rapid adoption cycle of these new AI tools is what we call this kind of leapfrog dynamic, where, you know, healthcare historically has been a laggard with respect to software-based technology. And we've alway…”
Yoo: Healthcare AI will increasingly be sold as digital labor
“We're at a breaking point where the industry needs these solutions, and therefore we're going to see a much higher adoption than we've ever seen before. I think it will come in the form of these super staff. I think we will increasingly see adoption of these A…”
Yoo: AI insurance lawsuits stem from denial speed, not denial rates
“The rate of denials is not going up, it's the speed with which the denials are happening that's going up.”
Yoo: Pandemic accelerates 10-year healthcare modernization trends into 2-3 years
“Now, all of those things were tailwinds that we thought would take 10 years or even longer to play out. But with the current dynamics at play during this pandemic it's more likely that those things will play out in two or three years.”